Succinylcholine Chloride
Succinylcholine Chloride Injection, USP
Approved
Approval ID
c7f409ed-e4f4-4cd6-8f37-93f505dd986d
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 19, 2023
Manufacturers
FDA
Zydus Lifesciences Limited
DUNS: 918596198
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Succinylcholine Chloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code70771-1352
Application NumberANDA209467
Product Classification
M
Marketing Category
C73584
G
Generic Name
Succinylcholine Chloride
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateOctober 19, 2023
FDA Product Classification
INGREDIENTS (6)
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
METHYLPARABENInactive
Quantity: 1.8 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SUCCINYLCHOLINE CHLORIDEActive
Quantity: 20 mg in 1 mL
Code: I9L0DDD30I
Classification: ACTIB
PROPYLPARABENInactive
Quantity: 0.2 mg in 1 mL
Code: Z8IX2SC1OH
Classification: IACT